Please sign the National Petition to Keep Synthetic Nicotine Legal! June 23 2022

Synthetic Nicotine Ban


A Citizens’ Petition on behalf of the American Vapor Manufacturers Association (AVM) has been posted to and is open for comments/support.

The petition is asking FDA to do the following:

  • Use its enforcement discretion to allow the continued marketing of open system products that use synthetic nicotine for which a premarket application (PMTA) has been submitted, through July 13, 2022, and until FDA completes its scientific review; and,
  • Allow for these manufacturers to continue submitting additional data and amendments for their application.


By way of background, In March 2020, FDA was granted the authority to regulate synthetic nicotine when President Biden signed the Omnibus Budget Bill. The language in the new law required manufacturers of synthetic nicotine products to submit PMTAs within 60 days (May 14, 2022) of the law taking effect to keep their products on the market for an additional 60 days (July 13, 2022).

The new law required vapor companies to produce highly technical, expensive, and scientifically rigorous premarket applications within 60 days. Similar to the roll-out of the 2016 deeming rule–which gave manufacturers only two years to submit applications that include studies that can take more than three years to complete–the new regulation of synthetic nicotine is almost entirely about taking products away from people who smoke and/or vape and punishing the industry rather than protecting consumers.

A previous Citizens’ Petition submitted by NJOY in 2017 likely contributed to the FDA’s announcement of comprehensive nicotine regulations that included a delay of the PMTA deadline from 2018 to 2022 for smoke-free products. While the environment has changed since then, FDA’s expanded authority over synthetic nicotine still allows for the agency to exercise its discretion with regard to PMTA enforcement. Neither court order nor act of congress has so far limited FDA’s ability to regulate with the protection of public health at the core of its actions.